INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

TRXBTRex Bio, Inc.

CIK 0002139097

EDGAR filingsOpen in network
Disclosed transactions16
Buys / sells3 / 0
Max Insider Score61
Connections5with evidence

TRXB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
47
AI
Alexandria Venture Investments, LLC10% Owner
TRXBTRex Bio, Inc.
Open-market purchase
BUY$2.50M
178.6K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Alexandria Venture Investments, LLC10% Owner · Oct 15, 2026
  • ← Insider ofevidence
    Svlsf Vi, Llc10% Owner · Oct 13, 2026
  • ← Insider ofevidence
    SV Life Sciences Fund VI (GP), L.P.10% Owner · Oct 13, 2026
9
AI
Alexandria Venture Investments, LLC10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C
—
1.17M sh
Oct 13, 2026
Oct 15, 2026
traded Oct 13, 2026
+2d
SEC FORM 4

Evidence

9
AI
Alexandria Venture Investments, LLC10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
1.03M sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

9
AI
Alexandria Venture Investments, LLC10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
3.48M sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

17
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
53.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

61
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Open-market purchase
BUY$1.26M
89.8K sh
Oct 8, 2026Oct 13, 2026
traded Oct 8, 2026
+5dSEC FORM 4

Evidence

17
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
1.57M sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

13
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
475.4K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

52
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Open-market purchase
BUY$43K
3,074 sh
Oct 8, 2026Oct 13, 2026
traded Oct 8, 2026
+5dSEC FORM 4

Evidence

13
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
16.3K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
669.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
1.57M sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
475.4K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
53.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
16.3K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

5
SV
Svlsf Vi, Llc10% Owner
TRXBTRex Bio, Inc.
Derivative conversion
C—
669.9K sh
Oct 13, 2026Oct 13, 2026
traded Oct 13, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    SV Life Sciences Fund VI, L.P.10% Owner · Oct 13, 2026